Nature BiotechnologyOvjeren akaunt

@NatureBiotech

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. Part of and .

NY/London/SF/LA/Heidelberg
Vrijeme pridruživanja: lipanj 2009.
Rođen/a 1. ožujka 1996.

Medijski sadržaj

  1. Assessing the impact of generative AI on medicinal chemistry

    Prikaži ovu nit
  2. Experts in bioengineering exploring how to transform biomedical discovery will be at . Submit an abstract or register today for this unmissable event

  3. Biotechnology's link to the walking dead?

  4. The n-Lorem Foundation intends to form the connective tissue between patients, researchers, facilities and regulators needed to supply individual patients with RNA therapies designed to treat their own ultra-rare disease—at no cost

  5. Biotech millionaire funds free drugs for ultra-rare diseases -

    , , i još njih 2
  6. The biotech living and the walking dead

  7. Reading amino acids in a nanopore. In a step toward nanopore sequencing of proteins, an aerolysin pore discriminates many of the proteinogenic amino acids

    Prikaži ovu nit
  8. Derek Lowe on FDA's about-face approval of Sarepta’s 2nd drug for muscular dystrophy (golodirsen) just months after sending the company a complete response letter, which enumerated multiple problems

  9. Senator Bernie Sanders threatens to create legislation to break patents for price gouging after BioMarin contemplates pricing its gene therapy for hemophilia

  10. Fresh from the biotech pipeline. The biopharma industry’s regulatory successes are piling up at a breathless pace. The new cohort of drugs is also rich with novelty; more than half the class of 2019 are first-in-class therapies and vaccines

  11. Championing leadership development in healthcare

    , , i još njih 3
  12. Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring

    Prikaži ovu nit
  13. Identifying drug targets in tissues and whole blood with thermal-shift profiling

    i
    Prikaži ovu nit
  14. Geneticists solve a 15-year-old mystery surrounding a cluster of sudden deaths among Amish children, when they discovered they all were homozygous for a duplication in the RYR2 gene, which causes cardiac arrhythmic disorder

  15. Prikaži ovu nit
  16. We launch our podcast series talking with Stefan Schneeberger about the significance of Clavien and colleagues' paper describing a sophisticated perfusion machine able to keep human livers alive outside the body for one week

  17. Fresh from the biotech pipeline. The biopharma industry’s positive regulatory momentum carried on through 2019, despite a government shutdown, a data manipulation scandal around a high-profile approval, and months without permanent leadership at the FDA

  18. Traditional valuation approaches rarely take into account scientific considerations specific to a R&D project. A question-based approach using real options offers a solution

    , , i još njih 2
    Prikaži ovu nit
  19. Vertical farms bear fruit. Engineering perishable crops for use in indoor farms promises to expand the adoption of this high-yielding, efficient means of food production

    Prikaži ovu nit
  20. In our first episode, Senior Editor talks to Stefan Schneeberger about the significance of a recent NBT paper by Pierre-Alain Clavien and colleagues describing a sophisticated perfusion machine to keep human livers alive for a week

    Prikaži ovu nit

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·